The Meyer Lab
Stanford Bone and Marrow Transplantation
The Meyer Lab research focuses on hematopoietic stem cell transplantation (HSCT) and Treg cell immunotherapy, with an emphasis on the treatment of graft-versus-host disease (GVHD) as well as immune tolerance induction for transplantation and autoimmunity. We are part of Stanford Medicine's Bone and Marrow Transplantation (BMT) department.
Bridging the gap between bench and bedside.
This website should allow you to review some of our published research, see our ongoing clinical trials, and get a feel for who's in the lab and what our culture is like. You can also find out how to contact us. We hope you enjoy your visit!
Latest Stanford Medicine News
-
Stanford Health AI Week & RAISE Health
Speakers focused on artificial intelligence in health and medicine — from the misuse of AI technology and how to avoid it, to the unique opportunities for developing AI technologies in pediatrics.
-
Advance in creating organoids could aid research, lead to treatment
Stanford Medicine researchers developed a way to create the first heart and liver organoids that generate their own blood vessels, possibly paving the way for organoid-based regenerative therapies.
-
AI lets clinicians ‘chat’ with health records
ChatEHR, artificial intelligence software developed at Stanford Medicine, is expediting chart reviews and other tasks by allowing clinicians to ask questions of medical records.